-
Something wrong with this record ?
Endobronchial involvement as an extremely rare manifestation of the Waldenström's disease
H. Bartáková, J. Novák, R. Jakša, J. Beneš, J. Votruba,
Language English Country England, Great Britain
Document type Case Reports
NLK
Medline Complete (EBSCOhost)
from 2007-07-01
ROAD: Directory of Open Access Scholarly Resources
from 2007
PubMed
27696747
DOI
10.1111/crj.12567
Knihovny.cz E-resources
- MeSH
- Bronchoscopy methods MeSH
- Fatal Outcome MeSH
- Risk Assessment MeSH
- Immunohistochemistry MeSH
- Biopsy, Needle MeSH
- Combined Modality Therapy methods MeSH
- Humans MeSH
- Bronchial Neoplasms diagnosis etiology therapy MeSH
- Tomography, X-Ray Computed methods MeSH
- Disease Progression MeSH
- Antineoplastic Combined Chemotherapy Protocols administration & dosage MeSH
- Aged MeSH
- Rare Diseases MeSH
- Waldenstrom Macroglobulinemia complications diagnosis MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Publication type
- Case Reports MeSH
Pulmonary infiltration is an infrequent organ involvement in Waldenström's disease (WD). Diffuse infiltration, isolated parenchymatous nodules, and pleural effusion are the most common manifestations of WD, while endobronchial mass is extremely rare. We present a case report of a 66-year-old man with a long-standing history of WD, who developed febrile neutropenia after therapy with rituximab, cyclophosphamide, and dexamethasone. X-ray and CT scan showed consolidation consistent with right-sided pneumonia. Surprisingly, bronchoscopy revealed an endobronchial tumor obstructing the right lower lobe (RLL) and two smaller granulations. Biopsies were obtained and recanalization of the RLL bronchus was performed. Immunohistological staining of the samples was consistent with lymphoplasmacytic lymphoma. Despite the change in therapy the patient died 6 weeks later. A review of published literature revealed only two case reports of endobronchial involvement in WD to this day. While one of the case reports described a patient with diffuse submucosal infiltration of the airways, the other one presented a patient with bronchus-obstructing tumor similar to the case reported here.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18034069
- 003
- CZ-PrNML
- 005
- 20181015102150.0
- 007
- ta
- 008
- 181008s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/crj.12567 $2 doi
- 035 __
- $a (PubMed)27696747
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Bartáková, Hana $u Department of Tuberculosis and Respiratory Diseases, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 245 10
- $a Endobronchial involvement as an extremely rare manifestation of the Waldenström's disease / $c H. Bartáková, J. Novák, R. Jakša, J. Beneš, J. Votruba,
- 520 9_
- $a Pulmonary infiltration is an infrequent organ involvement in Waldenström's disease (WD). Diffuse infiltration, isolated parenchymatous nodules, and pleural effusion are the most common manifestations of WD, while endobronchial mass is extremely rare. We present a case report of a 66-year-old man with a long-standing history of WD, who developed febrile neutropenia after therapy with rituximab, cyclophosphamide, and dexamethasone. X-ray and CT scan showed consolidation consistent with right-sided pneumonia. Surprisingly, bronchoscopy revealed an endobronchial tumor obstructing the right lower lobe (RLL) and two smaller granulations. Biopsies were obtained and recanalization of the RLL bronchus was performed. Immunohistological staining of the samples was consistent with lymphoplasmacytic lymphoma. Despite the change in therapy the patient died 6 weeks later. A review of published literature revealed only two case reports of endobronchial involvement in WD to this day. While one of the case reports described a patient with diffuse submucosal infiltration of the airways, the other one presented a patient with bronchus-obstructing tumor similar to the case reported here.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a protokoly protinádorové kombinované chemoterapie $x aplikace a dávkování $7 D000971
- 650 _2
- $a jehlová biopsie $7 D001707
- 650 _2
- $a nádory průdušek $x diagnóza $x etiologie $x terapie $7 D001984
- 650 _2
- $a bronchoskopie $x metody $7 D001999
- 650 _2
- $a kombinovaná terapie $x metody $7 D003131
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a fatální výsledek $7 D017809
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a vzácné nemoci $7 D035583
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a počítačová rentgenová tomografie $x metody $7 D014057
- 650 _2
- $a Waldenströmova makroglobulinemie $x komplikace $x diagnóza $7 D008258
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Novák, Jan $u Department of Internal Medicine and Haematology, Third Faculty of Medicine, Charles University in Prague and Faculty Hospital Královské Vinohrady, Prague, Czech Republic.
- 700 1_
- $a Jakša, Radek $u Institute of Pathology, General University Hospital, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Beneš, Jiří $u Department of Radiology, General University Hospital, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Votruba, Jiří $u Department of Tuberculosis and Respiratory Diseases, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 773 0_
- $w MED00188823 $t The clinical respiratory journal $x 1752-699X $g Roč. 12, č. 2 (2018), s. 816-819
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27696747 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181015102646 $b ABA008
- 999 __
- $a ok $b bmc $g 1340421 $s 1031063
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 12 $c 2 $d 816-819 $e 20161031 $i 1752-699X $m The clinical respiratory journal $n Clin Respir J $x MED00188823
- LZP __
- $a Pubmed-20181008